Advance your MedTech business with digital health solutions & innovative devices

Advancing medical technology is essential for overcoming global health challenges. From reversing the rise in chronic diseases, to minimising the rising cost of healthcare. By embracing digital health solutions and developing state-of-the-art devices, MedTech companies can advance early diagnostics and preventive care, helping to redefine patient care by making it personalised, efficient, and accessible.

With over 50 years of experience in the MedTech industry at Zühlke, we're committed to empowering this transformation, harnessing our health ecosystem network and deep expertise in digital health solutions, medical IoT, regulated device development, value engineering, and AI to drive substantial, tangible results.

We accelerate your route to market, boost your efficiency and help you embed modern technologies at the heart of your operations. So you can proactively meet the needs of tomorrow’s healthcare professionals and citizens.

Brain scans on a tablet

AI in Healthcare: Transforming Potential into Reality

AI has the power to revolutionise healthcare, but how can organisations navigate its complexities and unlock true value? Our whitepaper offers a roadmap to implementing AI responsibly and effectively, highlighting opportunities, challenges, and practical steps for success in this rapidly evolving field.

Wayne Wee, breathonix
' With Zühlke, we found a partner with proven technical expertise within the healthcare industry. The team’s practical insights and strategic guidance on technical infrastructure and data governance enabled us to scale our solutions for the next phase of growth. '
Wayne Wee
Head of Strategy & Business Development, Breathonix

Advance your MedTech business with digital health solutions

Accelerate innovation, streamline time-to-market and reduce operating costs with our health and technology expertise. We help you deliver innovative solutions that prioritise efficiency and adaptability for healthcare professionals today, while also focusing on future-oriented applications for healthy users to ensure sustained success.

  • Fast, efficient route to product launch

    Interdisciplinary expertise and well-oiled processes are becoming ever more important for successful product development. They enable medical technology companies to compete in the marketplace in the face of ever shorter innovation cycles – and reduce time to market.

    Learn more
  • Modular architecture enables global success

    Competing in global markets is increasingly important, but imposes a significant regulatory burden. Medical device development is becoming ever more complex. A modular system architecture facilitates the development of products for different markets and enables sophisticated update and upgrade systems that future-proof your products.

    Learn more
  • Getting it right on technology investments

    Penetration of new technologies depends on many different decisions – for example where you focus your development budget. Interdisciplinary teams and proven engineering techniques can help you find your way through the jungle of product definitions and digital technologies.

    Read more
  • Value-based healthcare – a big opportunity

    What effect has a treatment actually had? For MedTech companies, this question is increasingly important. It’s clear that value-based healthcare will require secure medical apps and connected devices. First-movers can expect to realise significant competitive advantages, for example through innovative new payment models.

    Learn more
  • Biometric sensors for personalised therapy

    Personalised medicine needs data – data from sources such as advanced biometric sensors. Pioneering medical technology companies are also using medical apps to collect data and thereby developing novel, integrated solutions offering genuine benefits for patients and new revenue streams for providers.

    Learn more

Medical technology companies increasingly have to compete in international markets while at the same time dealing with ever shorter innovation cycles. Time to market is a key factor for successful products – and knowledge gaps represent a serious risk. To realise rapid, reliable product development, companies need well-oiled, tried and tested processes and interdisciplinary expertise.

With over 50 years of medical technology experience, that’s exactly what Zühlke offers. Through our interdisciplinary teams, we provide you with wide-ranging mechanical engineering, electronics and software expertise. We take responsibility for tasks ranging from design controls to implementing risk mitigation measures to GxP-compliant manufacturing support. We can bring connectivity to your products to enable efficient monitoring and remote maintenance while maintaining compliance with all relevant regulations.

In an era of ever shorter product and innovation cycles, Zühlke provides everything you need to develop market-ready products quickly and reliably – helping you secure your competitive edge.

Leading life sciences company Eppendorf wanted to boost its innovation capacity and cement its position as a profitable, high growth business. Find out how Zühlke helped them use agile development to boost its commercial efficiency:

New market entrants represent an increasing challenge to established medical device companies. These new players are fast growing, innovative and in some cases enjoy significant cost and price advantages. This challenge is exacerbated by the increasingly stringent regulatory requirements for new medical products. This makes it harder for leading European medical device companies to penetrate new markets.

Zühlke can help you overcome these challenges. Our experts can help you build modular system architectures. These architectures create a foundation for developing different products for different markets, and enable the deployment of sophisticated update and upgrade systems to boost the longevity of your products. You also benefit from our in-depth understanding of the overall development cycle, our cost-reducing value engineering methodology, and our regulatory and technology expertise.

The result: innovative, cost-effective, regulatory-compliant medical devices. Ensuring that you’re in perfect shape to succeed in the hard-fought global markets of the future.

From preventive medicine to more accurate disease prognoses to optimised therapies, data-driven innovations are creating new opportunities for medical technology companies to provide patients with better, more individual support. But to be successful in this field, you have to make the right investment decisions. Getting these decisions right requires a sound understanding of connected devices, digital biomarkers, AI diagnostics, regulatory-compliant cloud architectures, wearables, and above all patient need.

Using interdisciplinary teams and proven engineering techniques like UX prototyping, Zühlke guides you through the jungle of product definitions and digital technologies. With Zühlke, you make the right investments at the right time. We make sure your investments produce a positive return and ensure your patient-centric, data-driven ecosystem makes the grade.

Advanced Osteotomy Tools (AOT) developed the world's first medical device to cut bone using a non-contact laser ablation procedure. Learn how Zühlke supported AOT with a deep learning image recognition system and an operational scale data platform:

For governments and health insurers, rising healthcare spending represents a major challenge. They are increasingly demanding evidence that medical products and therapies deliver genuine value. But a value-based healthcare approach is predicated on measurable treatment outcomes. For connected medical technology solutions, real-time collection and analysis of patient and treatment data is therefore becoming more and more important.

Zühlke has the expertise to realise innovative, integrated solutions on your behalf. We provide you with secure medical apps and connected devices that support AI data analysis tools and that users love. We can also draw up and evaluate new business models on your behalf, enabling you to set up innovative payment models for hospitals, pharmaceutical companies, health insurers, public sector organisations and patients.

Individually tailored therapies require highly advanced biometric sensors and biomarkers. End user devices play a key role in collecting and in analysing relevant data – whether for diagnosis, for predicting disease prognosis or for supporting the patient. 

By exploiting the ease of use of familiar devices such as smartphones, medical apps and related software solutions can be used to improve existing products. This enables medical technology companies to use their expertise to create new, standalone, integrated solutions.

We develop biometric sensors for you, enable you to use them intelligently and take care of secure connectivity to enable real-time control of your devices. We also help you use information and services to generate real value for patients, and at the same time develop new revenue streams.

Healios AG develops digital biomarkers to make life easier for multiple sclerosis patients and advance research into the disease. Get the interview with CEO Guilhem Dupont here, the latest company to join the Zühlke Ventures portfolio:

Guitar with zühlke logo

Stay connected with us

Subscribe to receive the latest news, insights, and exclusive event invitations from Zühlke.

Gain MedTech insights from our people, partners, and peers

Explore our latest research, insights, and perspectives on the most important trends and opportunities in MedTech.

Unlocking revenue through health innovation

How can you create new revenue streams through digital health solutions? Explore a tried and tested blueprint for uncovering commercial and societal value with digital health service innovation.

Demystify & capture value from AI

Struggling to find value-driving use cases? Discover how we can help you ideate, build, and scale bespoke AI solutions that deliver tangible efficiency gains and sustainable returns.

Let´s tackle your MedTech challenges together!

Meet our healthcare & medical devices leaders

  • portrait photo of Angeli Möller, Group Chief Health Officer

    Angeli Möller

    Group Chief Health Officer

  • Daniel Wilhelm Zühlke

    Daniel Wilhelm

    Managing Director Health Switzerland

    CV

    Daniel Wilhelm is a Managing Director Health Switzerland at Zühlke. His responsibility comprises sales and engagement management to deliver innovative products and services for the Health Tech industry. He is passionate to combine expertise in business and technology with a solution-oriented mindset to empower project teams and delight customers.

  • Helmut Taumberger

    Helmut Taumberger

    Managing Director Cross Markets, Austria

    CV

    With his years of experience and a strong innovative mindset, Helmut Taumberger is digital transformation personified. As a Managing Director Cross Markets in Austria, he is responsible for steering the company’s strategic orientation and development. A qualified engineer, he has worked in the IT sector since 2003 and has lent his substantial expertise to various international businesses. He likes nothing more than coming up with practical strategies and getting people excited about technological change.

  • Jim Lim

    Jim Lim

    Managing Director Health Singapore

    CV

    With more than 25 years of ICT industry experience, Jim brings a wealth of experience providing business and strategic advice to clients regionally. Having held various leadership positions across enterprises, Jim was also the founding CEO of Good Doctor Technology. Jim has worked with clients across multiple industry verticals, including healthcare and pharmaceutical. As Head of Health Industry Singapore, Jim will expand Zühlke’s healthcare expertise and offerings to healthcare and pharmaceutical companies in Singapore. 

  • Jürgen Pronebner

    Regional Managing Director Health Industry, EMEA & Partner

    CV

    As one of the first employees at Zühlke Germany, Jürgen Pronebner has helped to shape the Zühlke journey. Currently he acts as Regional Managing Director Health Industry, EMEA. He is a Member of the Zühlke Ventures Advisory Board and a long-time Partner in the Zühlke Group.

  • Kevin Murray

    Kevin Murray

    Managing Director Health UK